No Photo Available

Last Update

2016-12-18T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Horowitz?

Mr. David J. Horowitz

Director of Office of Compliance

The FDA Symposium

HQ Phone: (760) 365-0837

Email: h***@***.gov

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The FDA Symposium

100 North 20Th Street 4Th Floor

Philadelphia, Pennsylvania 19103

United States

Company Description

The FDA Symposium has been designed and produced by Health Care Conference Administrators, L.L.C. (HCCA) and FDAnews. FDAnews has been serving professionals in the pharmaceutical and medical device industries for more than 30 years. In addition to publi ... more

Find other employees at this company (1)

Background Information

Employment History

Assistant Professor of Radiation Oncology

Columbia University

Chief Resident, Department of Radiation Oncology

New York Presbyterian Hospital

Senior Public Health Policy Analyst

Centers for Medicare and Medicaid Services

Co-Chair

Project End Gun Violence

Research Aide

U.S. Food and Drug Administration

Affiliations

Member of the Coordinating Committee
Washington DC Film Society

Education

BA

Public Policy

Brown University

JD

University of Virginia

Web References (149 Total References)


Usersclub

www.labcompliance.com [cached]

Update from David Horowitz, US FDA, on FDA's 21 st Century GMP Initiative

...
David Horowitz, Director, Office of Compliance, FDA CDER, gave an update on current status, future plans and upcoming announcements on FDA's drug GMP initiative at the joint FDA/PDA joint regulatory conference. Horowitz gave specific examples for topics such as "Encouraging best manufacturing practices", "Risk-based approaches", "Enhanced coordination", "Consistency",and "Predictability and international collaboration". He also gavec an overview of FDA's Steering Committee and 15 active working groups.


Home | Contact | Books | Audio |

www.labcompliance.com [cached]

Mark B. McClellan, MD., PhD; Commissioner of Food and Drugs, Janet Woodcock, MD. ; CDER Director David Horowitz, Director of CDER's Office of Compliance, Joseph Famulare, Director, Div. of Manufacturing & Product Quality Office of Compliance, CDER/FDA


Update from David Horowitz, ...

www.compliancewebsite.com [cached]

Update from David Horowitz, US FDA, on FDA's 21 st Century GMP Initiative

...
David Horowitz, Director, Office of Compliance, FDA CDER, gave an update on current status, future plans and upcoming announcements on FDA's drug GMP initiative at the joint FDA/PDA joint regulatory conference. Horowitz gave specific examples for topics such as "Encouraging best manufacturing practices", "Risk-based approaches", "Enhanced coordination", "Consistency",and "Predictability and international collaboration". He also gavec an overview of FDA's Steering Committee and 15 active working groups.


David Horowitz, Director of ...

www.compliancewebsite.com [cached]

David Horowitz, Director of CDER's Office of Compliance

Gives FDA's perspective for a more formal dispute resolution process.
...
David Horowitz, Director of CDER's Office of Compliance
makes a clear statement that FDA warning letters will speak louder than ever now. Mr. Horowitz explained why and about the consequences for the industry.
...
David Horowitz, Director of CDER's Office of Compliance
Horowitz makes a clear statement that FDA's GMP initiative is not an initiative for deregulation.
...
David Horowitz, Director of CDER's Office of Compliance


FDA's New Jersey District Office Aims To Improve Company Drug Manufacturing: New Jersey Drug Litigation Lawyers -

www.druglitigationlawyers.com [cached]

The idea that using PAT will uncover problems was put in perspective by David Horowitz, the director of CDER's Office of Compliance. "We'll also find more solutions to problems, which will preclude regulatory action," he said.

Similar Profiles

Other People with this Name

Other people with the name Horowitz

Jacob Horowitz
ITN

Jill Horowitz
Greater Fort Lauderdale Chamber of Commerce

Spencer Horowitz
Deloitte LLP

Mo Horowitz
CEB Inc.

Rita Horowitz
The Everest Equity Company

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory